|View printer-friendly version|
|BrainStorm Names Dr. June S. Almenoff and Arturo O. Araya to its Board of Directors as Company Prepares for Clinical and Commercial Success|
"Dr. Almenoff and Mr. Araya are talented and successful pharmaceutical executives whose appointments come at an exciting time for our company," said
Dr. Almenoff is currently an independent biopharma consultant and Board Director. She is Executive Chair of RDD Pharma and a Director of
Dr. Almenoff graduated from the M.D. Ph.D. program at the
"I'm delighted to be joining the Board of Brainstorm," said Dr. Almenoff. "The Company's innovative work shows promise toward helping ALS patients with this devastating disease."
"It is an honor to be part of the Board of Brainstorm," said Mr. Araya. "The technology being developed at the Company has the potential to help ALS patients in great need of new treatment options."
VIBERZI® is a registered trademarks of
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/brainstorm-names-dr-june-s-almenoff-and-arturo-o-araya-to-its-board-of-directors-as-company-prepares-for-clinical-and-commercial-success-300413763.html